Zacks Research Brokers Raise Earnings Estimates for CVSA

Adtalem Global Education Inc. (NYSE:CVSA) – Equities research analysts at Zacks Research raised their Q3 2027 earnings estimates for shares of Adtalem Global Education in a research report issued on Thursday, August 20th. Zacks Research analyst Team now forecasts that the company will earn $2.35 per share for the quarter, up from their prior forecast of $2.13. The consensus estimate for Adtalem Global Education’s current full-year earnings is $9.00 per share. Zacks Research also issued estimates for Adtalem Global Education’s FY2027 earnings at $8.98 EPS.

Several other equities analysts have also recently weighed in on CVSA. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of Adtalem Global Education in a report on Wednesday, August 19th. Wall Street Zen raised Adtalem Global Education from a “hold” rating to a “buy” rating in a research note on Saturday, August 8th. Truist Financial raised their target price on shares of Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday, May 11th. Finally, Barrington Research restated an “outperform” rating and set a $170.00 price target on shares of Adtalem Global Education in a report on Monday, June 8th. Two equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $155.00.

Adtalem Global Education Price Performance

Shares of NYSE:CVSA opened at $132.83 on Monday. The business’s 50 day moving average is $125.85. Adtalem Global Education has a 1 year low of $86.97 and a 1 year high of $156.26. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 0.45. The firm has a market capitalization of $4.52 billion, a P/E ratio of 18.87, a P/E/G ratio of 0.98 and a beta of 0.62.

Adtalem Global Education (NYSE:CVSA) last released its quarterly earnings results on Thursday, August 6th. The company reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.90 by $0.19. The company had revenue of $501.38 million during the quarter. Adtalem Global Education had a net margin of 12.87% and a return on equity of 20.88%. Adtalem Global Education has set its FY 2027 guidance at 8.900-9.150 EPS.

Institutional Investors Weigh In On Adtalem Global Education

A hedge fund recently bought a new stake in Adtalem Global Education stock. Kendall Capital Management bought a new position in shares of Adtalem Global Education Inc. (NYSE:CVSA) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 11,622 shares of the company’s stock, valued at approximately $1,449,000. Institutional investors and hedge funds own 98.84% of the company’s stock.

Insider Activity

In other Adtalem Global Education news, SVP Douglas G. Beck sold 4,526 shares of Adtalem Global Education stock in a transaction on Friday, August 7th. The shares were sold at an average price of $135.81, for a total value of $614,676.06. Following the completion of the sale, the senior vice president directly owned 28,544 shares of the company’s stock, valued at approximately $3,876,560.64. The trade was a 13.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Robert J. Phelan sold 2,186 shares of the company’s stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $135.15, for a total value of $295,437.90. Following the transaction, the chief financial officer directly owned 48,306 shares in the company, valued at approximately $6,528,555.90. This trade represents a 4.33% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 25,951 shares of company stock worth $3,470,783 in the last quarter. 2.50% of the stock is owned by corporate insiders.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.